The pharmacogenomics of HIV therapy

Pharmacogenomics J. 2001;1(4):243-53. doi: 10.1038/sj.tpj.6500069.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Antiretroviral Therapy, Highly Active / methods*
  • Antiretroviral Therapy, Highly Active / trends
  • HIV Infections / drug therapy*
  • HIV Infections / genetics*
  • HIV Protease Inhibitors / adverse effects
  • HIV Protease Inhibitors / therapeutic use
  • Humans
  • Pharmacogenetics / methods*
  • Pharmacogenetics / trends

Substances

  • HIV Protease Inhibitors